Bibliography
- SCHLEIFFER R, RAUL F: Nitric oxide and the digestive system in mammals and non-mammalian vertebrates. Comp. Biochem. Physiol. (1997) 118A:965–974.
- JUNG HC, MUN KH, PARK TC et al.: Role of nitric oxide in penile erection. Yonsei Med. J. (1997) 38:261–269.
- GOUGE RC, MARSHBURN P, GORDON BE, NUNLEY W, HUET-HUDSON YM: Nitric oxide as a regulator of em-bryonic development. Biol. Reproduction (1998) 58:875–879.
- THOMSEN LL, OLESEN J: Nitric oxide theory of mi-graine. Clin. NeuroscL (1998) 5:28–33.
- ESCOTT KJ, BEECH JS, HAGA KK et al.: Cerebroprotec-tive effect of the nitric oxide synthase inhibitors, 142-trifluoromethylpheny0 imidazole and 7-nitro inda-zole, after transient focal cerebral ischemia in the rat. J. Cerebral Blood Flow Metab. (1998) 18:281–287.
- MIYASAKA N, HIRATA Y: Nitric oxide and inflammatory arthritides. Life ScL (1997) 61:2073–2081.
- CLANCY RM, AMIN AR, ABRAMSON SB: The role of nitric oxide in inflammation and immunity. Arth. Rheum. (1998) 41:1–11.
- MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. (1991) 43:109–142.
- •One of the very thorough early reviews of NO in biological systems.
- BREDT D, SNYDER SH: Nitric oxide: a physiologic mes- senger molecule. Ann. Rev. Biochem. (1994) 63:175–195.
- •This article, and the following one, are also both quite com-plete compilations of the earlier NO biological literature.
- STUEHR DJ, GRIFFITH OW: Mammalian nitric oxide synthases. Adv. Enzym. Rel. Mol Biol. (1993) 65:287-346. •Vide supra.
- SHEARER BG, LEE S, FRANZMANN KW et al.: Conforma-tionally restricted arginine analogs as inhibitors of hu-man nitric oxide synthase. Bioorg. Med. Chem. Lett. (1997) 7:1763–1768.
- GRANT SK, GREEN BG, STIFFEY-WILUSZ J et al.: Struc-tural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Biochemistry (1998) 37:4174–4180.
- COWART M, KOWALUK EA, DAANEN JF et al.: Nitroaro-matic amino acids as inhibitors of neuronal nitric ox-ide synthase. J. Med. Chem. (1998) 41:2636–2642.
- HALLINAN EA, TSYMBALOV S, FINNEGAN PM et al.: Aceta-midine lysine derivative, N-(5 (S)-amino-6,7-hihydroxyhepty0-ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase. J. Med. Chem. (1998) 41:775–777.
- BABU BR, GRIFFITH OW: N5-(1-imino-3-buteny0 4-o-rnithine a neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J. Biol. Chem. (1998) 273:8882–8889.
- WEBBER RK, METZ SS, MOORE WM et al.: Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. J. Med. Chem. (1998) 41:96–101.
- HANSEN DW, JR., PETERSON KB, TRIVEDI M et al.: 2-Iminohomopiperidine salts as selective inhibitors of inducible nitric oxide synthase (iNOS). J. Med. Chem. (1998) 41:1361–1336.
- SHANKARAN K, DONNELLY KL, SHAH SK et al: Inhibi-tion of nitric oxide synthase by benzoxazolones. Bioorg. Med. Chem. Lett. (1997) 7:2887–2892.
- SHEARER BG, LEE S, OPLINGER JA et al.: Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. J. Med. Chem. (1997) 40:1901–1905.
- COLLINS JL, SHEARER BG, OPLINGER JA et al.: N-phenylamidines as selective inhibitors of human neu-ronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. J. Med. Chem. (1998) 41:2858–2871.
- JAFFREY SR, SNYDER SH: PIN: an associated protein in- hibitor of neuronal nitric oxide synthase. Science (1996) 274:774–777.
- •One of the few references to NOS-binding proteins. This protein does not appear to bind at the site described in this application.
- VENEMA VJ, JU H, ZOU R, VENEMA RC: Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. J. Biol. Chem. (1997) 272:28187–28190.
- •The binding of caveolins to cNOS may be similar to the bind-ing described in this application.
- MICHEL T, FEROL 0: Nitric oxide synthases: which, where, how and why? J. Clin. Invest. (1997) 100:2146–2152.
- CHEN AFY, O'BRIEN T, KATUSIC ZS: Transfer and ex-pression of recombinant nitric oxide synthase genes in the cardiovascular system. Trend Pharmacol. Sci. (1998) 19:276–286.
- ••A useful lead summary of NOS interactions with other cellu-lar elements.